EUVIMEDEUVIMED entdecken
Multizentrische StudieValidierungsstudieOpen Access · CC BY-NC-ND 4.0

Cerebrovascular reactivity MRI as a biomarker for cerebral small vessel disease–related cognitive decline: Multi‐site validation in the MarkVCID Consortium

Peiying Liu, Zixuan Lin, Kaisha Hazel, George Pottanat, Cuimei Xu, Dengrong Jiang, Jay J Pillai, Emma Lucke, Christopher E Bauer, Brian T Gold, Steven M Greenberg, Karl G Helmer und 18 weitere

Alzheimer's & Dementia · 2024-08 · 20 (8) · 5281-5289

DOI: 10.1002/alz.13888 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Alzheimer's & Dementia, 2024-07. Verfasst von Peiying Liu und 29 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Magnetic Resonance Imaging, Cerebral Small Vessel Diseases, Biomarkers. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIBIB NIH HHS, NINDS NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Vascular contributions to cognitive impairment and dementia (VCID) represent a major factor in cognitive decline in older adults. The present study examined the relationship between cerebrovascular reactivity (CVR) measured by magnetic resonance imaging (MRI) and cognitive function in a multi‐site study, using a predefined hypothesis. METHODS We conducted the study in a total of three analysis sites and 263 subjects. Each site performed an identical CVR MRI procedure using 5% carbon dioxide inhalation. A global cognitive measure of Montreal Cognitive Assessment (MoCA) and an executive function measure of item response theory (IRT) score were used as outcomes. RESULTS CVR and MoCA were positively associated, and this relationship was reproduced at all analysis sites. CVR was found to be positively associated with executive function. DISCUSSION The predefined hypothesis on the association between CVR and a global cognitive score was validated in three independent analysis sites, providing support for CVR as a biomarker in VCID. Highlights This study measured a novel functional index of small arteries referred to as cerebrovascular reactivity (CVR). CVR was positively associated with global cognition in older adults. This finding was observed in three independent cohorts at three sites. Our statistical analysis plan was predefined before beginning data collection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cognitive DysfunctionMagnetic Resonance ImagingCerebral Small Vessel DiseasesBiomarkersHumansMaleFemaleAgedCerebrovascular CirculationExecutive FunctionMental Status and Dementia TestsNeuropsychological Tests

Stichwörter der Autor:innen

Montreal Cognitive Assessmentblood oxygenation level dependentcarbon dioxidecerebrovascular reactivitycognitive functionmagnetic resonance imagingvascular cognitive impairmentvascular cognitive impairment and dementia

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Radiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Department of Diagnostic Radiology & Nuclear Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Department of Division of Neuroradiology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.
  • Department of Neuroscience, University of Kentucky, Lexington, Kentucky, USA.
  • Department of Neurology, Massachusetts General Hospital Stroke Research Center, Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Radiology, Massachusetts General Hospital, Charlestown, Massachusetts, USA.

ORCID-Profile: Hanzhang Lu

Förderung

  • NIBIB NIH HHS
  • NINDS NIH HHS
  • NIH HHS
  • NIA NIH HHS
  • National Institutes of Health

Zitieren

APA

Liu, P., Lin, Z., Hazel, K., Pottanat, G., Xu, C., Jiang, D., Pillai, J. J., Lucke, E., Bauer, C. E., Gold, B. T., Greenberg, S. M., Helmer, K. G., Jann, K., Jicha, G., Kramer, J., Maillard, P., Mulavelil, R. M., Rodriguez, P., Satizabal, C. L., …, & Lu, H. (2024). Cerebrovascular reactivity MRI as a biomarker for cerebral small vessel disease–related cognitive decline: Multi‐site validation in the MarkVCID Consortium. Alzheimer's & Dementia, 20(8), 5281-5289. https://doi.org/10.1002/alz.13888

Vancouver

Liu P, Lin Z, Hazel K, Pottanat G, Xu C, Jiang D, et al. Cerebrovascular reactivity MRI as a biomarker for cerebral small vessel disease–related cognitive decline: Multi‐site validation in the MarkVCID Consortium. Alzheimer's & Dementia. 2024;20(8):5281-5289. doi:10.1002/alz.13888

BibTeX
@article{Liu2024,
  author = {Liu, Peiying and Lin, Zixuan and Hazel, Kaisha and Pottanat, George and Xu, Cuimei and Jiang, Dengrong and Pillai, Jay J and Lucke, Emma and Bauer, Christopher E and Gold, Brian T and Greenberg, Steven M and Helmer, Karl G and Jann, Kay and Jicha, Gregory and Kramer, Joel and Maillard, Pauline and Mulavelil, Rachel M and Rodriguez, Pavel and Satizabal, Claudia L and Schwab, Kristin and Seshadri, Sudha and Singh, Herpreet and Velarde Dediós, Ángel G and Wang, Danny J J and Kalyani, Rita R and Moghekar, Abhay and Rosenberg, Paul B and Yasar, Sevil and Albert, Marilyn and Lu, Hanzhang},
  title = {Cerebrovascular reactivity MRI as a biomarker for cerebral small vessel disease–related cognitive decline: Multi‐site validation in the MarkVCID Consortium},
  journal = {Alzheimer's & Dementia},
  year = {2024},
  volume = {20},
  number = {8},
  pages = {5281--5289},
  doi = {10.1002/alz.13888}
}
Kostenlos starten →